Document is current
Any future updates will be listed below
-
Authors
Ghia, Paolo https://orcid.org/0000-0003-3750-7342
Brown, Jennifer R. https://orcid.org/0000-0003-2040-4961
Shadman, Mazyar https://orcid.org/0000-0002-3365-6562
Wendtner, Clemens-Martin https://orcid.org/0000-0003-2866-2260
-
Funding
Funding for this research was provided by:
BeOne Medicines Ltd.
- License Information
-
More Information
Article History
Received: 28 January 2026
Accepted: 7 May 2026
First Online: 14 May 2026
Declarations
:
: Paolo Ghia has received honoraria, consulting fees and research funding from AbbVie, AstraZeneca, BeOne Medicines, Bristol-Myers Squibb, Johnson & Johnson, Lilly, Merck Sharp & Dohme, and Roche. Jennifer R Brown has received research funding from BeOne Medicines, Gilead, iOnctura, Loxo/Lilly, MEI Pharma, Nagoon Therapeutics, and TG Therapeutics. JRB has received consulting fees from AbbVie, Acerta/AstraZeneca, Alloplex Biotherapeutics, BeOne Medicines, Bristol-Myers Squibb, EcoR1, Galapagos NV, Genentech/Roche, Grifols Worldwide Operations, InnoCare Pharma, Kite Pharma, Loxo/Lilly, Magnet Biomedicine, Merck, Numab Therapeutics, Nurix Therapeutics, Pfizer, and Pharmacyclics. Mazyar Shadman has received research funding from AbbVie, AstraZeneca, BeOne, Genentech, Genmab, Morphosys/Incyte, Mustang Bio, and Vincerx. MS has received consulting fees from AbbVie, Genentech, AstraZeneca, Genmab, Janssen, BeOne Medicines, Bristol-Myers Squibb, Morphosys/Incyte, Kite Pharma, Eli Lilly, Fate Therapeutics, Nurix, Merck, Pfizer, and Pierre Fabre. Clemens-Martin Wendtner has received honoraria, consulting fees and research funding from AstraZeneca, BeOne Medicines, and Johnson & Johnson.
: This article is based on previously conducted studies and does not involve any new studies of human or animal subjects performed by any of the authors; therefore, ethical approval and informed consent were not required.
